During the past decade, Centro de Investigacion Clinica Acelerada, S.C. conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 8 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Investigacion Clinica Acelerada, S.C." #1 sponsor was "Shire" with 5 trials, followed by "Celgene" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Investigacion Clinica Acelerada, S.C." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Investigacion Clinica Acelerada, S.C." are "Ulcerative Colitis" (5 trials), "Crohn Disease" (4 trials), "Crohn's Disease" (3 trials), "Heart Failure" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Centro de Investigacion Clinica Acelerada, S.C." in a lesser frequency.

Most popular intervention types in "Centro de Investigacion Clinica Acelerada, S.C." are "Drug" (14 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "Empagliflozin" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigacion Clinica Acelerada, S.C." are 15 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Investigacion Clinica Acelerada, S.C.". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centro de Investigacion Clinica Acelerada, S.C., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigacion Clinica Acelerada, S.C., 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".